期刊文献+

急性ST段抬高型心肌梗死尿激酶原溶栓后早期介入与直接介入疗效对比研究 被引量:34

Early routine post-prourokinase thrombolysis percutaneous coronary intervention vs primary PCI in ST-segment elevated myocardial infarction: a comparative study
下载PDF
导出
摘要 目的 比较急性ST段抬高心肌梗死(STEMI)重组人尿激酶原溶栓后早期经皮冠状动脉介入治疗(PCI)与直接PCI的疗效.方法 2014年1月至2015年6月就诊于我院STEMI患者69例,根据治疗方法将患者分为尿激酶原溶栓后早期PCI组和直接PCI组,分别对两组患者梗死相关动脉(IRA)的再通率、并发症发生率、支架植入术、住院期间死亡率及1个月后患者左室射血分数(LVEF)等指标进行比较分析.结果 溶栓后早期PCI组共纳入32例患者,直接PCI组共纳入37例患者.术前溶栓后早期介入组血管开通率为87.5%(18.7%为TIMIⅡ级血流,68.8%为TIMIⅢ级血流),直接PCI组为18.9%(10.8%为TIMIⅡ级血流,8.1%为TIMIⅢ级血流),两组比较差异有统计学意义(p<0.01).两组PCI术后血管再通率相似,分别为90.6%和89.8%(P=0.653),但尿激酶原溶栓早期PCI组所用支架数更少.两组住院期间不良事件发生率(大出血、再闭塞、急性型左心衰和住院天数)无显著差异.1个月后随访LVEF、LVEDd、心源性死亡、再梗、脑卒中等未见统计学差异.结论 尿激酶原溶栓后早期PCI治疗是一种有效、安全的替代再灌注策略. Objective Compare the efficacy early routine post-prourokinase thrombolysis percutaneous coronary intervention(early PCI) with primary percutaneous coronary intervention(PPCI) for acute ST-segment elevated myocardial infarction (STEMI).Methods In January 2014 June 2015,69 patients were treated with STE-MI in our hospital.The patients were divided into early PCI group and primary PCI group.The incidence rate,complication rate,mortality rate,and left ventricular ejection fraction (LVEF) were compared between two groups.Results 32 patients in early PCI group and 37 in PPCI group were finally included.87.9% with early PCI group (18.7% Thrombolysis in myocardial infarction trial TIMI-2,68.8%TIMI-3),and 18.9% with primary PCI group (10.8% TIMI-2,8.1%TIMI-3)(P〈0.01).The blood flow rates were similar in the two groups after PCI operation,90.6%(early PCI group),and 89.8%(primary PCI group)(P=0.653),but the number of stents used in the early PCI group was less in primary PCI group.There was no significant difference in the incidence of adverse events in the two groups during hospitalization (major bleeding,acute left heart failure,and length of hospital stay).After 1 months of follow-up,there were no significant differences in LVEF,LVEDd,cardiac death,myocardial infarction again,and stroke.Conclusion Early routine post-prourokinase thrombolysis PCI is an effective and safe reperfusion therapy strategy.
出处 《中国心血管病研究》 CAS 2017年第5期433-436,共4页 Chinese Journal of Cardiovascular Research
基金 山东省医药卫生科技发展计划项目(项目编号:2014ws0024)
关键词 急性ST段抬高型心肌梗死 溶栓 经皮冠状动脉介入治疗 尿激酶原 Acute ST-segment elevation myocardial infarction Thrombolysis Percutaneous coronary intervention Prourokinase
  • 相关文献

参考文献2

二级参考文献37

  • 1陈韵岱,宋现涛,吕树铮,朱华刚,潘伟琦,宁尚秋,康铁朵.12小时内就诊的急性心肌梗死患者治疗现状分析[J].中国介入心脏病学杂志,2005,13(1):5-8. 被引量:67
  • 2杨艳敏,朱俊,谭慧琼,梁岩,章晏,李建东,刘力生,CREATE中国课题组.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2182. 被引量:86
  • 3中华医学会心血管病学分会.经皮冠状动脉介入治疗指南[J].中华心血管病杂志,2009,37:2-25. 被引量:12
  • 4Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet,1996, 21:771-775. 被引量:1
  • 5Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coil Cardiol,2004 ,44 :671-719. 被引量:1
  • 6Wang TY, Peterson ED, Ou FS, et al. Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: a report from the national cardiovascular data registry. Am Heart J,2011,161:76-83. 被引量:1
  • 7Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol,2003 ,92 :824-826. 被引量:1
  • 8Assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention (ASSENT-4 PCI ) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI) :randomised trial. Lancet, 2006,367:569-578. 被引量:1
  • 9Ellis SG, Tendera M, de Belder MA, et al. 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE ( facilitated intervention with enhanced reperfusion speed to stop events) trial. JACC Cardiovasc Interv,2009 ,2 :909-916. 被引量:1
  • 10Borgia F, Goodman SG, Halvorsen S, et al, Early routine pereutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a rneta-analysis. Eur Heart J,2010,31:2156-2169. 被引量:1

共引文献76

同被引文献303

引证文献34

二级引证文献237

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部